Stripping patent protection from Covid-19 treatments is a "mind-bogglingly stupid" idea, the head of a leading pharmaceutical lobby said Wednesday, warning that the move would put industry innovation at risk. Therefore, an IP waiver "potentially undermining what worked so well in this pandemic is basically mind-bogglingly stupid", Cueni said.
